ALCJ.PA
Price:
$2.075
Market Cap:
$107.53M
Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Industry
Medical - Instruments & Supplies
IPO Date
2014-02-20
Stock Exchange
PAR
Ticker
ALCJ.PA
According to Crossject S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -9.43. This represents a change of 71.93% compared to the average of -5.48 of the last 4 quarters.
The mean historical PE Ratio of Crossject S.A. over the last ten years is -8.40. The current -9.43 PE Ratio has changed 11.13% with respect to the historical average. Over the past ten years (40 quarters), ALCJ.PA's PE Ratio was at its highest in in the December 2011 quarter at 4.45. The PE Ratio was at its lowest in in the December 2010 quarter at -28.90.
Average
-8.40
Median
-7.07
Minimum
-21.17
Maximum
-1.51
Discovering the peaks and valleys of Crossject S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 321.33%
Maximum Annual PE Ratio = -1.51
Minimum Annual Increase = -71.70%
Minimum Annual PE Ratio = -21.17
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.85 | -62.91% |
| 2023 | -21.17 | 98.62% |
| 2022 | -10.66 | 57.58% |
| 2021 | -6.76 | -8.37% |
| 2020 | -7.38 | 15.87% |
| 2019 | -6.37 | 321.33% |
| 2018 | -1.51 | -71.70% |
| 2017 | -5.34 | 9.95% |
| 2016 | -4.86 | -59.74% |
| 2015 | -12.07 | -4.85% |
The current PE Ratio of Crossject S.A. (ALCJ.PA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-13.22
5-year avg
-10.76
10-year avg
-8.40
Crossject S.A.’s PE Ratio is less than Median Technologies S.A. (-3.42), less than Sensorion S.A. (-3.51), less than OSE Immunotherapeutics S.A. (-3.12), less than AB Science S.A. (-8.57), less than Klea Holding (49.76), greater than ABIONYX Pharma S.A. (-26.69), less than Innate Pharma S.A. (-2.84), greater than Adocia S.A. (-10.47), less than Eurofins-Cerep S.A. (14.57), less than Affluent Medical S.A. (-3.82),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.42 | $142.05M | |
| -3.51 | $98.55M | |
| -3.12 | $110.24M | |
| -8.57 | $84.19M | |
| 49.76 | $72.93M | |
| -26.69 | $122.58M | |
| -2.84 | $141.40M | |
| -10.47 | $119.85M | |
| 14.57 | $89.78M | |
| -3.82 | $56.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crossject S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Crossject S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Crossject S.A.'s PE Ratio?
How is the PE Ratio calculated for Crossject S.A. (ALCJ.PA)?
What is the highest PE Ratio for Crossject S.A. (ALCJ.PA)?
What is the 3-year average PE Ratio for Crossject S.A. (ALCJ.PA)?
What is the 5-year average PE Ratio for Crossject S.A. (ALCJ.PA)?
How does the current PE Ratio for Crossject S.A. (ALCJ.PA) compare to its historical average?